-
Symbol
-
LYEL on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001
-
Latest Disclosed Ownership
-
1.9M shares
-
Security Ownership
-
9.8%
Innovative Cellular Therapeutics Holdings Ltd ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL)
2025-11-13 - Innovative Cellular Therapeutics Holdings Ltd has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.9M shares of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL).
This represents 9.8% percent ownership of the company.